Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan 26;25(7):1265-9.
doi: 10.1016/j.vaccine.2006.10.007. Epub 2006 Oct 18.

DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau

Affiliations

DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau

Peter Aaby et al. Vaccine. .

Abstract

Background: The sequence of routine immunisations may be important for childhood mortality. Three doses of diphtheria-tetanus-pertussis vaccine (DTP) should be given at 6, 10, and 14 weeks and measles vaccine (MV) at 9 months of age. The sequence is not always respected. We examined in-hospital mortality of children having received DTP with or after measles vaccine.

Setting: The only paediatric ward in Bissau, Guinea-Bissau.

Participants: Children hospitalised during two periods in 1990-1996 and 2001-2002 who had received MV prior to hospitalisation.

Main outcome measure: The all-cause case fatality at the hospital for children aged 6-17 months.

Result: The case fatality was increased for children who had received DTP with or after measles vaccine compared with children who had received measles vaccine as the most recent vaccine, the ratio being 2.53 (1.37-4.67) and 1.77 (0.92-3.41) in the two periods, respectively. The combined estimate was 2.10 (1.34-3.28). These results were not explained by differences in nutritional status, number of doses of DTP or discharge policy.

Conclusion: Administration of DTP with, or after MV, may reduce the beneficial effect of MV.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources